A detailed history of Jane Street Group, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 57,116 shares of AXGN stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,116
Previous 73,262 22.04%
Holding current value
$1.05 Million
Previous $530,000 50.94%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $14.69 $121,417 - $237,184
-16,146 Reduced 22.04%
57,116 $800,000
Q2 2024

Aug 14, 2024

BUY
$5.67 - $8.06 $311,129 - $442,276
54,873 Added 298.4%
73,262 $530,000
Q1 2024

May 15, 2024

SELL
$6.63 - $10.69 $379,534 - $611,949
-57,245 Reduced 75.69%
18,389 $148,000
Q4 2023

Feb 14, 2024

BUY
$3.61 - $7.76 $273,038 - $586,919
75,634 New
75,634 $516,000
Q2 2023

Aug 14, 2023

BUY
$8.5 - $10.38 $85,748 - $104,713
10,088 New
10,088 $92,000
Q2 2022

Aug 16, 2022

BUY
$6.99 - $10.0 $167,438 - $239,540
23,954 New
23,954 $196,000
Q3 2018

Nov 14, 2018

SELL
$34.05 - $55.9 $135,927 - $223,152
-3,992 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$36.15 - $52.5 $144,310 - $209,580
3,992 New
3,992 $201,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $774M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.